Skip to main content

Table 2 Patient characteristics (PICU group, 19 patients)

From: Evolution of inspiratory muscle function in children during mechanical ventilation

Age (months), median (Q1–Q3)

13.7 (1.5–34)

Weight (kg), median (Q1–Q3)

11 (3.8–17.3)

Sex, male (%)

12 (63.2%)

Comorbidity, n (%)

 Prematurity

6 (31.6%)

 Previous episode of invasive ventilation (within 7 days of intubation)

3 (15.8%)

Reason for PICU admission, n (%)

 Neurological (traumatic brain injury)

1 (5.3%)

 Neurological (excluding traumatic brain injury)

4 (21.1%)

 Respiratory-upper airway

4 (21.1%)

 Respiratory-lower airway/pulmonary

7 (36.8%)

 Sepsis/shock

1 (5.3%)

 Other

2 (10.5%)

Reason for intubation, n (%)

 Neurological

4 (21.1%)

 Apnea

3 (15.8%)

 Respiratory-upper airway

4 (21.1%)

 Respiratory-lower airway/pulmonary

6 (31.6%)

 Hemodynamics

1 (5.3%)

 Procedure

1 (5.3%)

Drugs used during study period, n (%)

 Paralysis (excluding for intubation)

5 (26.3%)

 Corticosteroids

8 (42.1%)

 Inotropes/vasodilators

5 (26.3%)

Spontaneous mode used during MV episode (NAVA/PSV), n (%)

14 (73.7%)

Number of measurements, median (Q1–Q3)

3 (2.5–4)

PICU outcomes

 Duration of MV (hours), median (Q1–Q3)

63.9 (50.4–77.4)

 Reintubation within 24 h of extubation, n (%)

0 (0%)

 Rescue NIV for more than 72 h post-extubation, n (%)

2 (10.5%)

 PICU length of stay (days), median (Q1–Q3)

5.3 (4–8.8)

 Died during PICU admission, n (%)

0 (0%)

  1. PICU pediatric intensive care unit, Q1–Q3 first and third quartiles, NAVA neurally adjusted ventilatory assist, PSV pressure-support ventilation, MV mechanical ventilation, NIV non-invasive ventilation